Covalent Chemistry-Mediated Multimarker Purification of Circulating Tumor Cells Enables Noninvasive Detection of Molecular Signatures of Hepatocellular Carcinoma.
circulating tumor cells
click chemistry
hepatocellular carcinoma
nanosubstrate
transcriptome profiling
Journal
Advanced materials technologies
ISSN: 2365-709X
Titre abrégé: Adv Mater Technol
Pays: United States
ID NLM: 101717732
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
ppublish
Résumé
Transcriptomic profiling of tumor tissues introduces a large database, which has led to improvements in the ability of cancer diagnosis, treatment, and prevention. However, performing tumor transcriptomic profiling in the clinical setting is very challenging since the procurement of tumor tissues is inherently limited by invasive sampling procedures. Here, we demonstrated the feasibility of purifying hepatocellular carcinoma (HCC) circulating tumor cells (CTCs) from clinical patient samples with improved molecular integrity using Click Chips in conjunction with a multimarker antibody cocktail. The purified CTCs were then subjected to mRNA profiling by NanoString nCounter platform, targeting 64 HCC-specific genes, which were generated from an integrated data analysis framework with 8 tissue-based prognostic gene signatures from 7 publicly available HCC transcriptomic studies. After bioinformatics analysis and comparison, the HCC CTC-derived gene signatures showed high concordance with HCC tissue-derived gene signatures from TCGA database, suggesting that HCC CTCs purified by Click Chips could enable the translation of HCC tissue molecular profiling into a noninvasive setting.
Identifiants
pubmed: 34212072
doi: 10.1002/admt.202001056
pmc: PMC8240468
mid: NIHMS1707763
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : R21 CA216807
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA218356
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA235340
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA255727
Pays : United States
Organisme : NIBIB NIH HHS
ID : U01 EB026421
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA240887
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA198900
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA253651
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA246304
Pays : United States
Déclaration de conflit d'intérêts
Conflict of Interest The authors declare no conflict of interest.
Références
Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2467-2472
pubmed: 29453278
Cancer Cell. 2008 Dec 9;14(6):471-84
pubmed: 19061838
Liver Transpl. 2018 Jul;24(7):946-960
pubmed: 29624843
Nat Rev Clin Oncol. 2014 Mar;11(3):129-44
pubmed: 24445517
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1123-1128
pubmed: 28096363
Angew Chem Int Ed Engl. 2013 Mar 18;52(12):3379-83
pubmed: 23436302
Sci Adv. 2019 Jul 31;5(7):eaav9186
pubmed: 31392269
Adv Mater. 2020 Jan;32(1):e1903663
pubmed: 31566837
Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17296-301
pubmed: 16301537
Sci Transl Med. 2013 Apr 3;5(179):179ra47
pubmed: 23552373
N Engl J Med. 2004 Aug 19;351(8):781-91
pubmed: 15317891
Clin Cancer Res. 2008 Oct 1;14(19):6302-9
pubmed: 18829513
Theranostics. 2019 Apr 13;9(10):2812-2826
pubmed: 31244925
Cell Syst. 2019 Jul 24;9(1):24-34.e10
pubmed: 31344359
Hepatology. 2004 Sep;40(3):667-76
pubmed: 15349906
Clin Cancer Res. 2016 Mar 1;22(5):1256-64
pubmed: 26459179
Adv Healthc Mater. 2018 Feb;7(3):
pubmed: 28892262
Nature. 2012 Mar 28;483(7391):603-7
pubmed: 22460905
Acc Chem Res. 2014 Oct 21;47(10):2941-50
pubmed: 25111636
Angew Chem Int Ed Engl. 2009;48(47):8970-3
pubmed: 19847834
NPJ Precis Oncol. 2020 Jul 2;4:16
pubmed: 32637655
ACS Nano. 2014 Mar 25;8(3):1995-2017
pubmed: 24601556
Hepatology. 2009 Mar;49(3):1017-44
pubmed: 19243014
Hum Pathol. 2017 May;63:1-13
pubmed: 28087475
Nat Rev Cancer. 2014 Sep;14(9):623-31
pubmed: 25154812
Nat Biotechnol. 2014 May;32(5):441-3
pubmed: 24811515
J Clin Oncol. 2018 Feb 20;36(6):572-580
pubmed: 29272162
Cancer Res. 2010 Apr 15;70(8):3034-41
pubmed: 20395200
Clin Cancer Res. 2011 Jun 1;17(11):3783-93
pubmed: 21527564
Angew Chem Int Ed Engl. 2011 Mar 21;50(13):3084-8
pubmed: 21374764
Cancer Res. 2009 Sep 15;69(18):7385-92
pubmed: 19723656
Adv Mater. 2013 Jun 4;25(21):2897-902
pubmed: 23529932
Brief Bioinform. 2018 Mar 1;19(2):286-302
pubmed: 27881428
Hepatology. 2021 Jan;73(1):422-436
pubmed: 32017145
Cell. 2011 Jan 21;144(2):296-309
pubmed: 21241896
Nat Commun. 2020 Sep 7;11(1):4489
pubmed: 32895384
Adv Drug Deliv Rev. 2018 Feb 1;125:78-93
pubmed: 29551650
Gastroenterol Clin North Am. 2017 Jun;46(2):311-325
pubmed: 28506367
ACS Nano. 2015 Jan 27;9(1):62-70
pubmed: 25495128
Chem Soc Rev. 2017 Apr 18;46(8):2038-2056
pubmed: 28393954
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Cell Physiol Biochem. 2015;37(2):629-40
pubmed: 26344495
Science. 2002 Jan 25;295(5555):647-51
pubmed: 11809963
Hepatology. 2012 May;55(5):1443-52
pubmed: 22105560